Novel Cyclic Peptides Inhibiting Tumor Necrosis Factor Receptor 1 Activity
ACS Med Chem Lett. 2025 Jan 23;16(3):363-365. doi: 10.1021/acsmedchemlett.5c00011. eCollection 2025 Mar 13.ABSTRACTThis patent application pertains to macrocyclic peptides, generally represented by Formula I. These compounds exhibit selective binding to tumor necrosis factor receptor 1 (TNFR1) and h